Literature DB >> 1306094

Nicotine and cotinine in the cervical mucus of smokers, passive smokers, and nonsmokers.

M F McCann1, D E Irwin, L A Walton, B S Hulka, J L Morton, C M Axelrad.   

Abstract

Although epidemiological studies suggest that cigarette smoking is a risk factor for cervical cancer, further evidence is required to document the biological plausibility of this relationship. This study obtained cervical mucus, using a cervical flush technique, from 50 patients in a neoplasia clinic. Nicotine was detected in the cervical mucus of all 25 smokers and cotinine in the mucus of 84% of the smokers; nicotine and cotinine levels were correlated (P < or = 0.10) with both the number of cigarettes usually smoked and the number smoked in the last 24 h. Nicotine and cotinine levels for passive smokers and nonexposed women were much lower than for women who currently smoked, with little difference found between the nonsmoking women who did and did not report passive smoke exposure. In the one woman who reported smokeless tobacco use, both nicotine and cotinine were detected at much higher levels than for other nonsmoking women. These results indicate that tobacco constituents do indeed reach the uterine cervix, suggesting that they could play a causal role in the development of cervical cancer.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1306094

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  23 in total

1.  Risk factors for cervical cancer in criminal justice settings.

Authors:  Ingrid A Binswanger; Shane Mueller; C Brendan Clark; Karen L Cropsey
Journal:  J Womens Health (Larchmt)       Date:  2011-10-17       Impact factor: 2.681

2.  Tobacco exposure results in increased E6 and E7 oncogene expression, DNA damage and mutation rates in cells maintaining episomal human papillomavirus 16 genomes.

Authors:  Lanlan Wei; Anastacia M Griego; Ming Chu; Michelle A Ozbun
Journal:  Carcinogenesis       Date:  2014-07-26       Impact factor: 4.944

3.  Cigarette smoke stimulates VEGF-C expression in cervical intraepithelial neoplasia (CIN) 1 and 2 lesions.

Authors:  Morihiko Inamine; Yutaka Nagai; Akira Mitsuhashi; Satoru Nagase; Nobuo Yaegashi; Hiroyuki Yoshikawa; Yoichi Aoki
Journal:  Int J Clin Oncol       Date:  2011-09-27       Impact factor: 3.402

4.  Spontaneous regression of high-grade cervical dysplasia: effects of human papillomavirus type and HLA phenotype.

Authors:  Cornelia L Trimble; Steven Piantadosi; Patti Gravitt; Brigitte Ronnett; Ellen Pizer; Andrea Elko; Barbara Wilgus; William Yutzy; Richard Daniel; Keerti Shah; Shiwen Peng; Chienfu Hung; Richard Roden; Tzyy Choou Wu; Drew Pardoll
Journal:  Clin Cancer Res       Date:  2005-07-01       Impact factor: 12.531

Review 5.  Does the vaginal microbiota play a role in the development of cervical cancer?

Authors:  Maria Kyrgiou; Anita Mitra; Anna-Barbara Moscicki
Journal:  Transl Res       Date:  2016-07-15       Impact factor: 7.012

6.  The cigarette smoke carcinogen benzo[a]pyrene enhances human papillomavirus synthesis.

Authors:  Samina Alam; Michael J Conway; Horng-Shen Chen; Craig Meyers
Journal:  J Virol       Date:  2007-11-07       Impact factor: 5.103

7.  Cytokine profile in cervical mucosa of Japanese patients with cervical intraepithelial neoplasia.

Authors:  Takashi Iwata; Takuma Fujii; Kenji Morii; Miyuki Saito; Juri Sugiyama; Hiroshi Nishio; Tohru Morisada; Kyoko Tanaka; Tomonori Yaguchi; Yutaka Kawakami; Daisuke Aoki
Journal:  Int J Clin Oncol       Date:  2014-03-01       Impact factor: 3.402

8.  From human papillomavirus (HPV) to cervical cancer: psychosocial processes in infection, detection, and control.

Authors:  S M Miller; W Mischel; A O'Leary; M Mills
Journal:  Ann Behav Med       Date:  1996

9.  Damage to DNA in cervical epithelium related to smoking tobacco.

Authors:  A M Simons; D H Phillips; D V Coleman
Journal:  BMJ       Date:  1993-05-29

10.  Dysregulation of human beta-defensin-2 protein in inflammatory bowel disease.

Authors:  Marian C Aldhous; Colin L Noble; Jack Satsangi
Journal:  PLoS One       Date:  2009-07-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.